Virtus ETF Advisers LLC Cue Biopharma, Inc. Transaction History

Virtus ETF Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $35,559 - $84,543	-14,281 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $3,722 - $10,364	-844 Reduced 5.58%	14,281 $70,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $5,549 - $9,121	-511 Reduced 3.27%	15,125 $171,000
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $8,168 - $12,423	-812 Reduced 4.94%	15,636 $228,000
Q2 2021 Aug 10, 2021	SELL	$10.9 - $14.53 $61,094 - $81,440	-5,605 Reduced 25.42%	16,448 $192,000
Q1 2021 May 17, 2021	BUY	$11.2 - $16.09 $4,401 - $6,323	393 Added 1.81%	22,053 $269,000
Q4 2020 Feb 12, 2021	BUY	$11.12 - $16.4 $106,740 - $157,423	9,599 Added 79.59%	21,660 $271,000
Q3 2020 Nov 13, 2020	SELL	$15.05 - $23.54 $24,937 - $39,005	-1,657 Reduced 12.08%	12,061 $182,000
Q2 2020 Aug 05, 2020	BUY	$12.7 - $30.73 $174,218 - $421,554	13,718 New	13,718 $336,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $35.4M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.